Understanding genetic testing support for Aussie IRD patients
People living with an inherited eye disease (IRD) who have received genetic testing are invited to participate in a national ...
People living with an inherited eye disease (IRD) who have received genetic testing are invited to participate in a national ...
Melbourne researchers are developing a new gene therapy they hope will “switch on sight” by regenerating light-sensing photoreceptor cells in ...
Prominent Melbourne retinal disease researcher Professor Robyn Guymer is encouraged by the Phase 3 results of a trial she’s been ...
Australia’s nurses are at the centre of a survey that will create a snapshot of the eyecare nurse workforce and ...
Eyetelligence is a new Australian-developed AI system helping clinicians screen for three types of eye disease. PROFESSOR MING HE – ...
Orthoptics is a versatile field with many opportunities and diverse career options that will continually evolve and expand. Whether you ...
Australia’s first clinical trials of an investigational gene therapy for dry age-related macular degeneration (AMD) has commenced at the Centre ...
Two years since the KeepSight launch, Insight asks what measurable difference this once-in-a-generation program is making to those living with ...
The managing director of one of Australia’s pre-eminent eye research institutions is a leading scientist behind experiments on mice that ...
Australian-owned teleophthalmology and clinical communication platform Oculo will change hands in the coming months following an announcement this week that ...
Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.
© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited